Peking University School of Transnational Lawģ60 Furman St Apt 312, Brooklyn, NY 11201-4582
Third Judicial Department (seated in Albany)Ģ6th Floor, Gloucester Tower, The Landmark, 15 Queen’s Road Central, Central, Hong Kong, -, CHINAįloor 22, Bank of China Tower, 1 Garden Road, Central, HONG KONGĪttorneys with the same company Attorney NameĢ6th Floor, Gloucester Tower The Landmark, 15 Queen's Road Central, Hong Kong, 999077, -, CHINAĦ01 Lexington Avenue, New York, NY 10022-Ģ00 Clarendon St Fl 48, Boston, MA 02116-5373ģ0th F., Gloucester Tower, The Landmark, 15 Queen's Rd., Central, Hong Kong, -, HONG KONGģ6-61, 601 Lexington Ave, New York, NY 10022-Ģ00 Clarendon St 47th Floor, Boston, MA 02116-ģ00 N Lasalle Dr., Chicago, IL 60654-3406Ħ01 Lexington Ave # 3440, New York, NY 10022-4611Ħ01 Lexington Ave, 44f, New York, NY 10022-Īttorneys with the same school Attorney Name
#JING DU NYC REGISTRATION#
Attorney Information Registration NumberĢ6th Floor, Gloucester Tower, The Landmark The current status of the attorney is Currently registered. The registered office location is at 26th Floor, Gloucester Tower, The Landmark, 15 Queen’s Road Central, Central, Hong Kong, -, CHINA, with contact phone number +85237613532. The attorney was graduated from University of Minnesota Law School.
Represented China Bohai Bank (HKSE: 9668), a national joint-stock commercial bank in China, in its US$1.JING DU (Registration # 5630496) is an attorney in Hong Kong admitted in the Third Judicial Department (seated in Albany) of New York State in 2019, registered with the Office of Court Administration (OCA) of New York State Unified Court System.Represented Morgan Stanley and CICC as the joint sponsors in the US$394.5 million global offering and listing of Cheerwin Group Limited (HKSE: 6601), a leading multi-category household care and personal care platform in China, on the Main Board of The Hong Kong Stock Exchange.Represented Morgan Stanley, CICC and Credit Suisse as the joint sponsors in the US$281 million global offering and listing of SciClone Pharmaceuticals (HKSE: 6600), a China-focused biopharmaceutical company specializing in oncology and severe infection, on the Main Board of the Hong Kong Stock Exchange.Prior to joining Kirkland & Ellis, Jing's representative experience includes:
0 kommentar(er)
